Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-protein kinase 2 (ALPK2) is a serine/threonine protein kinase that belongs to the alpha-protein kinase family, characterized by an unusual alpha-type kinase domain distinct from canonical kinases[1][2][6]. ALPK2 recognizes and phosphorylates protein substrates with surrounding alpha-helical conformations[6]. It plays significant roles in cellular processes such as epicardium morphogenesis, heart development, cardiomyocyte differentiation—where it acts by negatively regulating the Wnt/beta-catenin signaling pathway—and the regulation of gene expression and luminal apoptosis[2][5][6]. ALPK2 is implicated in cancer biology and has been associated with regulation of apoptosis and DNA repair in colonic crypts, suggesting a role in tumor development and possibly in cardiovascular disorders[1][5]. While its physiological functions are increasingly understood, no clinically approved drugs specifically target ALPK2, and there are currently no established biomarkers or safety challenges unique to this kinase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-protein kinase 2 (ALPK2).